One main challenge in adopting AI in radiology is the lack of clear rules on how to use AI tools safely and well in clinical settings. AI software is often labeled as “software as a medical device” (SaMD). This changes how it is regulated. Many AI products have FDA approval, showing they meet safety and effectiveness standards. Still, healthcare practices need to test these tools themselves to make sure they work correctly with their patients and equipment.
The ARCH-AI program, led by the American College of Radiology (ACR), offers a national quality check system to help with this local testing. The program points out that radiology practices must have good infrastructure, rules, and monitoring systems for AI. Many hospital systems do not have these yet. As of early 2024, only 16% of health systems had an organization-wide AI governance policy, so most are still trying out or studying AI.
Another problem is that radiology staff have different levels of AI training and knowledge. A survey in Saudi Arabia asked CT technologists about their AI learning. It found only 9.1% had formal AI education and 19.2% learned on the job. Although this is not from the U.S., it shows a training gap that probably exists in the U.S. too. Without enough education, technologists, radiologists, and managers may not feel ready to use or manage AI systems well.
There are several wrong ideas that slow down AI progress in healthcare. These include worries about jobs, AI working on its own, and data privacy.
AI Will Replace Radiologists and Other Healthcare Workers
Many people worry that AI will take jobs from radiologists or CT technologists. A study in Saudi Arabia found 80% of workers disagreed that AI would hurt their jobs. Similar opinions exist in the U.S. AI is made to help radiologists by doing routine tasks and checking images again, but it does not make the final diagnosis.
Sam Schwager, CEO of SuperBill, says AI can help find early disease signs like cancer faster, but it cannot do the careful judgment, ethics, and care that health workers give.
AI Systems Are Infallible
Some believe that AI always gives perfect answers. Actually, AI results depend on the data used to teach it. If the training data is biased or messy, AI can give wrong diagnoses and cause unfair patient treatment. The “Clever Hans” effect happens when AI seems right but for the wrong reasons. This shows why humans need to watch AI and why AI should explain how decisions are made.
AI Implementation Is Too Expensive
AI tools might cost a lot at first, but many studies show they save money over time. They make work more efficient, cut down repeated tests, and improve patient care. AI can reduce paperwork and free medical staff to focus on harder tasks. This can make jobs better.
AI Poses Excessive Privacy Risks
Healthcare groups already follow strict rules like HIPAA to protect data. AI systems follow these rules too. Sometimes, AI can improve security by spotting hacking or strange activity better than older systems.
Good AI governance helps solve many problems and misunderstandings. Governance is not only about following rules. It’s about putting AI into current work with care, clear rules, and ethics.
A strong AI governance system includes:
The American College of Radiology created tools like AICentral.org, a list of FDA-approved AI imaging tools, and the Assess-AI registry, which collects data on AI performance in real settings.
AI systems trained in one place might not work well somewhere else. Dr. Christoph Wald from ACR says testing AI with local data is important to be sure it is safe and useful in that specific clinic.
Healthcare leaders and IT workers should:
FDA approval does not mean AI is perfect everywhere. Testing AI locally helps protect patients.
AI is not just for diagnosis. It can help automate office and admin tasks in radiology. For example, companies like Simbo AI use AI to answer calls, schedule appointments, and route patient questions.
For medical office managers and IT workers, AI automation can:
As AI automation grows, it is important to have good rules to keep patient privacy safe and workflows well organized. The success of AI depends on how well it fits into the whole patient experience—from booking appointments to sharing results.
For AI to work well in radiology, leaders must help staff feel ready and comfortable. The Saudi study showed people liked AI but lacked formal training. Similar training gaps may exist in the U.S.
Helpful steps include:
Training and building trust can lower resistance and improve how AI is used.
Healthcare AI in the U.S. follows rules like HIPAA to protect privacy and FDA approval to ensure safety. New standards from groups like the World Health Organization also matter. Following rules is key to protect patients and keep trust.
Ethical issues include avoiding bias in AI, making sure all patients have access to AI benefits, and clearly deciding who is responsible when AI helps with decisions. Good governance helps handle these challenges.
By focusing on these points, medical practice leaders and IT managers in the U.S. can handle the challenges and incorrect ideas about using AI in radiology. When done right, AI can improve diagnosis, speed up work, and help patients while following all legal and ethical rules.
The ARCH-AI program is a national quality assurance initiative by the ACR that provides a framework for the safe and effective implementation of AI in radiology practices.
It offers best practices for utilizing AI safely, outlining infrastructure, processes, and governance necessary for proper AI implementation.
They must prioritize issues to solve, evaluate AI performance locally, and consider factors such as cost, ease of integration, and user interface.
Some radiologists misunderstand AI tools as definitive diagnostic aids, rather than software that aids in triaging or detecting conditions requiring human oversight.
The program was created based on input from AI pioneers, designed to help practices develop AI governance and infrastructure for responsible implementation.
ACR offers AICentral.org for discovering AI products, and the Assess-AI registry for local acceptance testing and continuous monitoring of AI performance.
Monitoring ensures that AI tools maintain efficacy in local conditions, as performance may vary considerably between populations and practice environments.
FDA clearance indicates that an AI product has passed initial safety and efficacy tests, but practices must independently verify its performance in specific settings.
AICentral.org serves as a curated library for practices to review AI products, assisting in informed selection based on algorithm training and projected efficacy.
The program will evolve to incorporate user feedback and address growing technologies, including generative AI models, ensuring relevance in clinical environments.